Effects of Combined Training Protocol in Volleyball Players
Launched by KARABUK UNIVERSITY · Mar 8, 2025
Trial Information
Current as of May 09, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special training program on male volleyball players. Over 12 weeks, players will participate in different exercises, including jump training and jump rope sessions, to improve their performance and technical skills. At the beginning and end of the trial, players will be tested on various physical abilities, such as their vertical jump, sprint speed, and skills like serving and spiking. They will also share how they feel about the exercises they do.
To be eligible for this trial, participants must be healthy male volleyball athletes aged 18 and older who are willing to complete all training sessions. Those with chronic diseases or any conditions that prevent them from exercising will not be able to participate. This trial is currently active but not looking for new participants. Overall, it aims to help improve training methods for volleyball players by comparing different exercise techniques.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Being healthy
- • Male volleyball athletes
- • Willing to maintain the intervention for all sessions
- Exclusion Criteria:
- • Being under 18 years old
- • Having a chronic disease
- • Contraindications for exercise
About Karabuk University
Karabuk University is a distinguished educational institution located in Turkey, dedicated to advancing scientific research and innovation across various fields, including healthcare. As a clinical trial sponsor, the university plays a pivotal role in facilitating cutting-edge research aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodology, Karabuk University collaborates with healthcare professionals and researchers to design and implement clinical trials that address pressing health challenges, ultimately striving to enhance treatment options and promote public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karabük, , Turkey
Patients applied
Trial Officials
Neslihan Akçay, Doctorate
Study Chair
Karabuk University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported